report News - The Latest News, Insight, Commentary & Analysis at Healthcare Asia Magazine

report

Global wound care centres market to be valued at $58.7b by 2030

Advanced facilities are shifting to digitally enabled models.

7MM pulmonary arterial hypertension market to hit $9.3b by 2034

The treatment paradigm is shifting to proactive intervention.

Global hospital services to be valued at $24.17t by 2034

By hospital, the private hospital segment is anticipated to grow at the fastest rate.

Laparoscopic retrieval bag market to be valued at $985.7m by 2034

Thanks to a shift to minimally invasive surgical procedures.

Japan delays medical expense reforms amidst political pushback

Overall health spending is still expected to surpass 12% of GDP by 2029.

Health information exchange market to reach $4.44b by 2032

Thanks to a rising focus on interoperability and seamless data sharing.

Global venipuncture procedure market to hit $1.5b by 2030

Its growth is attributed to the increasing demand for diagnostic testing.

Single-use surgical instruments market to reach $7.8b by 2030

Thanks to the rise of minimally invasive, short-stay, and outpatient surgeries.

Endometriosis market across the 7MM to hit $2.5b by 2034

Its expansion is attributed to the introduction of several key therapies.

Pakistan’s drug import dependence poses risks to critical medicine supply

Pharmaceutical imports are expected to reach $920m by 2029.

Endoscopic hemostasis devices market eyes 3.6% CAGR growth through 2034

Ageing populations are undergoing more frequent endoscopic screenings.

Remote surgery technology platforms market to hit $10.52b by 2034

Its growth is attributed to the rising demand for minimally invasive surgeries.

Residual DNA testing market to be valued at $370m by 2030

India, China, Brazil, and Japan are rapidly scaling their biopharma capabilities.

Self-service kiosks for healthcare market to reach $3.77b by 2034

There is a growing adoption in hospitals, clinics, and pharmacies.

Global ophthalmology drugs market to hit $26.28b by 2030

Investments, strategic collaborations, and therapy advancements drive growth.